沢井製薬(株)企業情報
機関の空売り残高情報
計算日 | 空売り者 | 残高割合 | 増減率 | 残高数量 | 増減量 | 備考 |
---|---|---|---|---|---|---|
2013/03/22 | Nomura International | 0.470% | -0.010% | 74,355株 | -1,400 | |
2013/03/22 | Merrill Lynch international | 0.317% | +0.007% | 50,400株 | +1,200 | |
2013/03/21 | Nomura International | 0.480% | -0.010% | 75,755株 | -1,200 | |
2013/03/21 | Merrill Lynch international | 0.310% | +0.008% | 49,200株 | +1,200 | |
2013/03/21 | Jabre Cap MS | 0.590% | +0.127% | 93,400株 | +20,000 | |
2013/03/19 | Nomura International | 0.490% | -0.020% | 76,955株 | -3,800 | |
2013/03/19 | Merrill Lynch international | 0.302% | +0.022% | 48,000株 | +3,500 | |
2013/03/18 | Nomura International | 0.510% | +0.010% | 80,755株 | +800 | |
2013/03/18 | Merrill Lynch international | 0.280% | 0% | 44,500株 | ||
2013/03/15 | Nomura International | 0.500% | 0% | 79,955株 | +900 | |
2013/03/14 | Nomura International | 0.500% | 0% | 79,055株 | -300 | |
2013/03/13 | Nomura International | 0.500% | +0.220% | 79,355株 | +34,700 | |
2013/03/12 | Nomura International | 0.280% | 0% | 44,655株 | ||
2013/02/28 | AQR Capital Management | 0.940% | -0.010% | 149,700株 | -300 | |
2013/02/27 | AQR Capital Management | 0.950% | +0.010% | 150,000株 | +300 | |
2013/02/20 | AQR Capital Management | 0.940% | -0.010% | 149,700株 | -300 | |
2013/02/19 | AQR Capital Management | 0.950% | +0.010% | 150,000株 | +300 | |
2013/02/13 | AQR Capital Management | 0.940% | -0.010% | 149,700株 | -400 | |
2013/02/12 | AQR Capital Management | 0.950% | +0.010% | 150,100株 | +700 | |
2012/12/21 | Jabre Cap MS | 0.463% | 0% | 73,400株 | ||
2012/12/20 | AQR Capital Management | 0.940% | +0.010% | 149,400株 | +2,700 | |
2012/12/12 | AQR Capital Management | 0.930% | 0% | 146,700株 | ||
2012/11/26 | Morgan Stanley & Co. | 0.210% | -0.040% | 33,800株 | -7,200 | 報告義務消失 |
2012/11/22 | Morgan Stanley & Co. | 0.250% | -0.020% | 41,000株 | -2,100 | |
2012/11/21 | Morgan Stanley & Co. | 0.270% | 0% | 43,100株 |